AcquisitionOther
Pulmatrix, Inc. acquired Eos SENOLYTIX, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Pulmatrix, Inc. -> Eos SENOLYTIX, Inc. · $19 million
To advance novel mitochondrial therapies targeting aging-related diseases through the MitoXcel platform and PTC-2105 clinical candidate.
Open source record (SEC) ↗